Otto Zach

705 total citations
28 papers, 447 citations indexed

About

Otto Zach is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Otto Zach has authored 28 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Hematology. Recurrent topics in Otto Zach's work include Epigenetics and DNA Methylation (6 papers), Cancer Cells and Metastasis (6 papers) and Acute Myeloid Leukemia Research (4 papers). Otto Zach is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer Cells and Metastasis (6 papers) and Acute Myeloid Leukemia Research (4 papers). Otto Zach collaborates with scholars based in Austria, United States and Singapore. Otto Zach's co-authors include D. Lutz, H. Kasparu, Otto Krieger, Michael Girschikofsky, Klaus Geißler, Gerald Webersinke, Hans‐Christian Bauer, Hannelore Bauer, Albert Amberger and O. Krieger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Otto Zach

26 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto Zach Austria 10 216 176 176 67 36 28 447
Peder Fredlund Fuchs Sweden 7 141 0.7× 205 1.2× 102 0.6× 41 0.6× 72 2.0× 9 358
Tracey Amanda Martin United Kingdom 11 168 0.8× 265 1.5× 111 0.6× 70 1.0× 48 1.3× 15 478
R. Habets Netherlands 8 178 0.8× 357 2.0× 161 0.9× 56 0.8× 27 0.8× 8 535
Christine Bourcier France 9 79 0.4× 381 2.2× 115 0.7× 41 0.6× 42 1.2× 10 534
Sophie Thiolloy United States 7 192 0.9× 197 1.1× 168 1.0× 22 0.3× 33 0.9× 12 421
Elise Langenkamp Netherlands 8 197 0.9× 337 1.9× 152 0.9× 68 1.0× 162 4.5× 9 594
Matthew Ashenden United Kingdom 4 87 0.4× 224 1.3× 182 1.0× 42 0.6× 28 0.8× 4 369
Anie Monast Canada 10 189 0.9× 290 1.6× 97 0.6× 52 0.8× 190 5.3× 10 566
Nadine Abu-Kaoud Qatar 8 209 1.0× 405 2.3× 214 1.2× 45 0.7× 71 2.0× 9 663
Shi-Yuan Cheng United States 9 95 0.4× 306 1.7× 148 0.8× 32 0.5× 59 1.6× 9 412

Countries citing papers authored by Otto Zach

Since Specialization
Citations

This map shows the geographic impact of Otto Zach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Zach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Zach more than expected).

Fields of papers citing papers by Otto Zach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto Zach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Zach. The network helps show where Otto Zach may publish in the future.

Co-authorship network of co-authors of Otto Zach

This figure shows the co-authorship network connecting the top 25 collaborators of Otto Zach. A scholar is included among the top collaborators of Otto Zach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Zach. Otto Zach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Machherndl‐Spandl, Sigrid, Otto Zach, Gerald Webersinke, et al.. (2024). Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center Analysis. Cancers. 16(19). 3257–3257. 1 indexed citations
2.
Sperr, Wolfgang R., Otto Zach, Susanne Herndlhofer, et al.. (2016). Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post‐induction consolidation therapy. American Journal of Hematology. 91(12). 1239–1245. 9 indexed citations
3.
Webersinke, Gerald, Wolfgang Kranewitter, Otto Zach, et al.. (2014). Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?. Blood Cancer Journal. 4(6). e221–e221. 6 indexed citations
4.
Rudas, Margaretha, Anna S. Berghoff, Regina Promberger, et al.. (2014). BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy. Cancer Chemotherapy and Pharmacology. 73(4). 771–778. 20 indexed citations
5.
Geißler, Klaus & Otto Zach. (2012). Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway. Annals of Hematology. 91(5). 645–669. 37 indexed citations
6.
Zach, Otto, Maria Huber, Sigrid Machherndl‐Spandl, et al.. (2012). The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential Thrombocythemia. Leukemia Research. 36(5). 588–590. 2 indexed citations
7.
Klein, Georg, et al.. (2011). A novel 3′ splice-site mutation and a novel gross deletion in leukocyte adhesion deficiency (LAD)-1. Biochemical and Biophysical Research Communications. 404(4). 1099–1104. 9 indexed citations
8.
Pröll, Johannes, et al.. (2008). In vitro detection of methylated DNA via recombinant protein MBD2b. Molecular Biology Reports. 36(7). 1859–1862. 5 indexed citations
9.
Pröll, Johannes, et al.. (2008). Immunodetection Array. Methods in molecular biology. 507. 45–54. 1 indexed citations
10.
Pröll, Johannes, et al.. (2006). Ultra-Sensitive Immunodetection of 5'Methyl Cytosine for DNA Methylation Analysis on Oligonucleotide Microarrays. DNA Research. 13(1). 37–42. 22 indexed citations
11.
Zach, Otto & D. Lutz. (2005). Tumor cell detection in peripheral blood and bone marrow. Current Opinion in Oncology. 18(1). 48–56. 54 indexed citations
12.
Mache, Christoph J., Wolfgang Schwinger, Stephan Spendel, et al.. (2005). Skin transplantation to monitor clinical donor‐related tolerance in mixed hematopoietic chimerism. Pediatric Transplantation. 10(1). 128–131. 12 indexed citations
13.
Zach, Otto, H. Kasparu, H. Wagner, O. Krieger, & D. Lutz. (2002). Prognostic value of tumour cell detection in peripheral blood of breast cancer patients.. PubMed. 59. 32–4. 24 indexed citations
14.
Zach, Otto, et al.. (2001). Identification and localization of M-CoREST (1A13), a mouse homologue of the human transcriptional co-repressor CoREST, in the developing mouse CNS. Mechanisms of Development. 108(1-2). 165–169. 16 indexed citations
15.
Zach, Otto, et al.. (2001). Statistical Validation of the Mammaglobin-Nested RT-PCR Assay for Tumor Cell Detection in Blood of Breast Cancer Patients. BioTechniques. 31(6). 1358–1362. 9 indexed citations
16.
Zach, Otto, et al.. (2000). Mammaglobin as a Marker for the Detection of Tumor Cells in the Peripheral Blood of Breast Cancer Patients. Annals of the New York Academy of Sciences. 923(1). 343–345. 9 indexed citations
17.
Zach, Otto, et al.. (2000). [Detection of mammaglobin mRNA as a marker for circulating tumor cells in breast carcinoma].. PubMed. 52. 13–5. 3 indexed citations
18.
Zach, Otto, et al.. (1997). Expression of a Chemotactic Cytokine (MCP-1) in Cerebral Capillary Endothelial Cells in Vitro. Endothelium. 5(3). 143–153. 17 indexed citations
19.
Zach, Otto, et al.. (1995). Sequence of the porcine full-length cDNA encoding ribosomal protein rpS12. Gene. 159(2). 277–278. 1 indexed citations
20.
Bauer, Hannelore, Albert Amberger, Gerald Webersinke, et al.. (1993). Transcription‐Independent Activation of Ornithine Decarboxylase Activity by Heparin in Cloned Cerebral Endothelial Cells. Journal of Neurochemistry. 60(4). 1520–1524. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026